title: Risk groups in adult acute lymphoblastic leukemia.
authors.forename: D
authors.initials: D
authors.lastname: Hoelzer
authors.forename: E
authors.initials: E
authors.lastname: Thiel
authors.forename: H
authors.initials: H
authors.lastname: Löffler
authors.forename: A
authors.initials: A
authors.lastname: Ganser
authors.forename: H
authors.initials: H
authors.lastname: Heimpel
authors.forename: T
authors.initials: T
authors.lastname: Büchner
authors.forename: D
authors.initials: D
authors.lastname: Urbanitz
authors.forename: P
authors.initials: P
authors.lastname: Koch
authors.forename: M
authors.initials: M
authors.lastname: Freund
authors.forename: H
authors.initials: H
authors.lastname: Diedrich
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D012074:Remission Induction; D012306:Risk